X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Divis Laboratories with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs SUVEN LIFE - Comparison Results

DIVIS LABORATORIES    Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES SUVEN LIFE DIVIS LABORATORIES/
SUVEN LIFE
 
P/E (TTM) x 18.1 16.3 111.2% View Chart
P/BV x 3.9 3.0 129.7% View Chart
Dividend Yield % 1.6 1.2 127.4%  

Financials

 DIVIS LABORATORIES   SUVEN LIFE
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-16
SUVEN LIFE
Mar-16
DIVIS LABORATORIES/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs2,484339 733.7%   
Low Rs918144 635.8%   
Sales per share (Unadj.) Rs142.339.2 362.5%  
Earnings per share (Unadj.) Rs41.97.5 561.3%  
Cash flow per share (Unadj.) Rs46.38.8 528.0%  
Dividends per share (Unadj.) Rs10.002.00 500.0%  
Dividend yield (eoy) %0.60.8 71.0%  
Book value per share (Unadj.) Rs161.549.0 329.6%  
Shares outstanding (eoy) m265.47127.28 208.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x12.06.2 194.3%   
Avg P/E ratio x40.632.4 125.5%  
P/CF ratio (eoy) x36.727.5 133.4%  
Price / Book Value ratio x10.54.9 213.7%  
Dividend payout %23.926.8 89.1%   
Avg Mkt Cap Rs m451,52530,732 1,469.2%   
No. of employees `0003.71.0 388.7%   
Total wages/salary Rs m3,649416 876.4%   
Avg. sales/employee Rs Th10,184.45,236.1 194.5%   
Avg. wages/employee Rs Th984.1436.5 225.5%   
Avg. net profit/employee Rs Th2,998.5995.5 301.2%   
INCOME DATA
Net Sales Rs m37,7644,995 756.0%  
Other income Rs m848194 438.4%   
Total revenues Rs m38,6125,189 744.2%   
Gross profit Rs m14,1381,233 1,147.0%  
Depreciation Rs m1,182167 706.8%   
Interest Rs m2354 42.8%   
Profit before tax Rs m13,7811,205 1,143.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,662255 1,044.1%   
Profit after tax Rs m11,119950 1,170.7%  
Gross profit margin %37.424.7 151.7%  
Effective tax rate %19.321.2 91.3%   
Net profit margin %29.419.0 154.9%  
BALANCE SHEET DATA
Current assets Rs m30,9474,986 620.7%   
Current liabilities Rs m5,1951,042 498.5%   
Net working cap to sales %68.279.0 86.4%  
Current ratio x6.04.8 124.5%  
Inventory Days Days11761 191.4%  
Debtors Days Days8539 217.6%  
Net fixed assets Rs m17,0273,126 544.8%   
Share capital Rs m531127 417.0%   
"Free" reserves Rs m42,3413,717 1,139.0%   
Net worth Rs m42,8776,236 687.5%   
Long term debt Rs m5432 1.1%   
Total assets Rs m49,6848,079 615.0%  
Interest coverage x595.023.2 2,561.7%   
Debt to equity ratio x00.1 0.2%  
Sales to assets ratio x0.80.6 122.9%   
Return on assets %22.412.4 180.5%  
Return on equity %25.915.2 170.3%  
Return on capital %32.218.9 170.5%  
Exports to sales %85.387.5 97.4%   
Imports to sales %22.912.2 187.4%   
Exports (fob) Rs m32,1984,371 736.7%   
Imports (cif) Rs m8,654611 1,416.8%   
Fx inflow Rs m32,2704,666 691.5%   
Fx outflow Rs m8,775942 931.4%   
Net fx Rs m23,4963,724 630.9%   
CASH FLOW
From Operations Rs m10,379922 1,125.7%  
From Investments Rs m-4,135-619 667.6%  
From Financial Activity Rs m-6,241-698 893.7%  
Net Cashflow Rs m3-396 -0.8%  

Share Holding

Indian Promoters % 52.0 63.4 82.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.8 0.0 -  
FIIs % 19.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 36.5 47.1%  
Shareholders   31,796 37,287 85.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA  DR. REDDYS LAB  NOVARTIS  J.B.CHEMICALS  MERCK LTD  

Compare DIVIS LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Infosys Down 4.1%(09:30 am)

Asian stock markets opened mixed in early trade today. Hong Kong Hang Seng has advanced 143 points and China's Shanghai Composite has gained 9 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Aug 21, 2017 11:03 AM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS